Melanoma physicians and researchers from Penn Medicine and The Wistar Institute have been awarded a prestigious $12.1 million SPORE (Specialized Program of Research Excellence) grant from the National Cancer Institute. The five-year grant will fund four new melanoma research projects that aim to translate fundamental laboratory discoveries into new therapeutics to treat melanoma and other skin cancers. Department faculty involved in this SPORE project include Drs. Carl H. June, Michael Feldman, and George Xu, who will direct the Pathology Core.

Read the Department of Communications news release.